SCHEMBL25350786

SCHEMBL25350786

FC(F)c1nnc(-c2ccc(Cn3cc(-c4ccc5cn[nH]c5c4)nn3)nc2)o1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 9/20 0.48
▸ ROCK2 O75116 10/20 0.46
▸ GSK3B P49841 10/20 0.46
▸ PIM1 P11309 7/20 0.46
▸ AURKB Q96GD4 7/20 0.46
▸ CDC7 O00311 2/20 0.46
▸ AURKA O14965 2/20 0.46
▸ PRKCG P05129 2/20 0.46
▸ CDK1 P06493 2/20 0.46
▸ PRKACA P17612 2/20 0.46
▸ RPS6KB1 P23443 2/20 0.46
▸ CDK2 P24941 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ GSK3A P49840 2/20 0.46
▸ PRKAA1 Q13131 2/20 0.46
▸ ROCK1 Q13464 2/20 0.46
▸ DYRK1A Q13627 2/20 0.46
▸ CDC42BPA Q5VT25 2/20 0.46
▸ SGK2 Q9HBY8 2/20 0.46
▸ PLK4 O00444 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31535155 1.00 HDAC6 (0.48) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL25351342 0.93 ROCK2 (0.56) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL25352046 0.88 HDAC6 (0.52) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL25268143 0.88 ROCK2 (0.58) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL30425892 0.88 ROCK2 (0.58) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL25351235 0.87 ROCK2 (0.47) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL30409995 0.86 HDAC6 (0.47) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL24215733 0.86 HDAC6 (0.47) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL25349809 0.85 ROCK2 (0.55) HDAC6ROCK2GSK3BPIM1AURKB
SCHEMBL31535157 0.85 ROCK2 (0.55) HDAC6ROCK2GSK3BPIM1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 HDAC6 1/4885ROCK2 2366/4885GSK3B 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback